Results 171 to 180 of about 104,429 (337)
Prognostic Significance of Raynaud's Phenomenon and Other Clinical Characteristics of Systemic Scleroderma [PDF]
, 1960 Richard G. Farmer +2 more
openalex +1 more source
Medical geography and its contribution to the aetiology of rare systemic connective tissue diseases : a thesis presented in partial fulfilment of the requirements for the degree of Master of Arts in Geography at Massey University [PDF]
, 1975 This thesis is in two interrelated parts. Part One traced the historical development of medical geography since the idea of applying a geographical perspective to medical problems was first mooted in 4 B.C.
Borman, Graham Barry
core
Arthritis &Rheumatology, Volume 77, Issue 5, Page 571-581, May 2025.Objective Two randomized trials for patients with diffuse systemic sclerosis (SSc) demonstrated an overall survival (OS) and event‐free survival (EFS) advantage of autologous hematopoietic stem cell transplantation (AHSCT) using CD34+ selected peripheral blood stem cells (PBSCs) compared with monthly cyclophosphamide (CY).
George E. Georges +16 more
wiley +1 more source
Hematological Oncology, Volume 43, Issue 3, May 2025.ABSTRACT Localized light chain amyloidosis (loc‐AL) is a rare disorder characterized by localized deposition of misfolded AL fibrils. There are limited data on patterns of disease presentation and long‐term outcomes. In this study, we retrospectively reviewed 146 patients with loc‐AL at our institution between January 1, 2010, and March 1, 2024.
Danai Dima +11 more
wiley +1 more source
Erratum to “From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution”
Dermatology Research and Practice, 2018 Dilia Giuggioli +5 more
doaj +1 more source
Clinical Progress in Mesenchymal Stem Cell Therapy: A Focus on Rheumatic Diseases
Immunity, Inflammation and Disease, Volume 13, Issue 5, May 2025.ABSTRACT Background Rheumatic diseases are chronic immune‐mediated disorders affecting multiple organ systems and significantly impairing patients' quality of life. Current treatments primarily provide symptomatic relief without offering a cure. Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic option due to their ability to ...
Helal F. Hetta +7 more
wiley +1 more source